Table of Contents PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT PART 03: RESEARCH METHODOLOGY PART 04: MARKET LANDSCAPE • Market ecosystem • Market characteristics • Market segmentation analysis PART 05: MARKET SIZING • Market definition • Market sizing 2017 • Market size and forecast 2017-2022 PART 06: FIVE FORCES ANALYSIS • Bargaining power of buyers • Bargaining power of suppliers • Threat of new entrants • Threat of substitutes • Threat of rivalry • Market condition PART 07: MARKET SEGMENTATION BY PRODUCT • Segmentation by product • Comparison by product • Pharmaceutical • Feed additive • Biologicals • Market opportunity by product PART 08: CUSTOMER LANDSCAPE PART 09: REGIONAL LANDSCAPE • Geographical segmentation • Regional comparison • Americas • EMEA • APAC • Key leading countries • Market opportunity PART 10: DECISION FRAMEWORK PART 11: DRIVERS AND CHALLENGES • Market drivers • Market challenges PART 12: MARKET TRENDS • Growing animal healthcare awareness • Increasing M&A activity • Increase in consumer preference towards protein-rich food PART 13: VENDOR LANDSCAPE • Overview • Landscape disruption PART 14: VENDOR ANALYSIS • Vendors covered • Vendor classification • Market positioning of vendors • Bayer • Boehringer Ingelheim • Eli Lilly • Merck • Zoetis • Other prominent vendors • List of abbreviations List of Exhibits Exhibit 01: Related market Exhibit 02: Market characteristics Exhibit 03: Market segments Exhibit 04: Market definition - Inclusions and exclusions checklist Exhibit 05: Market size 2017 Exhibit 06: Validation techniques employed for market sizing 2017 Exhibit 07: Global – Market size and forecast 2017-2022 ($ bn) Exhibit 08: Global – Year over year growth 2018-2022 (%) Exhibit 09: Five forces analysis 2017 Exhibit 10: Five forces analysis 2022 Exhibit 11: Bargaining power of buyers Exhibit 12: Bargaining power of suppliers Exhibit 13: Threat of new entrants Exhibit 14: Threat of substitutes Exhibit 15: Threat of rivalry Exhibit 16: Market condition - Five forces 2017 Exhibit 17: Product – Market share 2017-2022 (%) Exhibit 18: Comparison by product Exhibit 19: Pharmaceutical – Market size and forecast 2017-2022 ($ bn) Exhibit 20: Pharmaceutical – Year over year growth 2018-2022 (%) Exhibit 21: Feed additive – Market size and forecast 2017-2022 ($ bn) Exhibit 22: Feed additive – Year over year growth 2018-2022 (%) Exhibit 23: Biologicals- Market size and forecast 2017-2022 ($ bn) Exhibit 24: Biologicals– Year over year growth 2018-2022 (%) Exhibit 25: Market opportunity by product Exhibit 26: Customer landscape Exhibit 27: Global – Market share by geography 2017-2022 (%) Exhibit 28: Regional comparison Exhibit 29: Americas – Market size and forecast 2017-2022 ($ bn) Exhibit 30: Americas – Year over year growth 2018-2022 (%) Exhibit 31: EMEA – Market size and forecast 2017-2022 ($ bn) Exhibit 32: EMEA – Year over year growth 2018-2022 (%) Exhibit 33: APAC – Market size and forecast 2017-2022 ($ bn) Exhibit 34: APAC – Year over year growth 2018-2022 (%) Exhibit 35: Key leading countries Exhibit 36: Market opportunity Exhibit 37: Diseases caused by animals and their mode of transmission to humans Exhibit 38: Vendor landscape Exhibit 39: Landscape disruption Exhibit 40: Vendors covered Exhibit 41: Vendor classification Exhibit 42: Market positioning of vendors Exhibit 43: Vendor overview Exhibit 44: Bayer – Business segments Exhibit 45: Bayer – Organizational developments Exhibit 46: Bayer – Geographic focus Exhibit 47: Bayer – Segment focus Exhibit 48: Bayer – Key offerings Exhibit 49: Vendor overview Exhibit 50: Boehringer Ingelheim– Business segments Exhibit 51: Boehringer Ingelheim – Organizational developments Exhibit 52: Boehringer Ingelheim– Geographic focus Exhibit 53: Boehringer Ingelheim– Segment focus Exhibit 54: Boehringer Ingelheim– Key offerings Exhibit 55: Vendor overview Exhibit 56: Eli Lilly– Business segments Exhibit 57: Eli Lilly– Organizational developments Exhibit 58: Eli Lilly– Geographic focus Exhibit 59: Eli Lilly– Segment focus Exhibit 60: Eli Lilly– Key offerings Exhibit 61: Vendor overview Exhibit 62: Merck– Business segments Exhibit 63: Merck– Organizational developments Exhibit 64: Merck– Geographic focus Exhibit 65: Merck– Segment focus Exhibit 66: Merck– Key offerings Exhibit 67: Vendor overview Exhibit 68: Zoetis– Business segments Exhibit 69: Zoetis– Organizational developments Exhibit 70: Zoetis– Geographic focus Exhibit 71: Zoetis– Segment focus Exhibit 72: Zoetis– Key offerings

Bayer, Boehringer Ingelheim, Eli Lilly, Merck, and Zoetis